Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
life sciences
national blog main
boston blog main
clinical trials
boston
boston top stories
national top stories
rna interference
alnylam pharmaceuticals
deals
drugs
new york blog main
new york top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
akcea therapeutics
alexion pharmaceuticals
alirocumab
alnylam
alnylam pharmaceutials
amgen
arena pharmaceuticals
arrowhead pharmaceuticals
artie suckow
barry greene
biology
biopharma
boehringer ingelheim
boston university
cancer
dan ollendorf
dicerna pharmaceuticals
drug delivery
dtx pharma
duchenne
eli lilly
What
rna
6
×
medicines
new
ago
alnylam
based
betting
companies
deal
diseases
fda
historic
long
medicine
pharma
small
treat
abandoning
addition
advance
alltrna
announced
approval
approve
awaits
baggage
billion
biological
biologics
biopharma
called
cholesterol
company
considered
crossed
curious
cuts
data
decades
decision
Language
unset
Current search:
rna
×
biotech
×
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision